Connection
Robert Jotte to Kelch-Like ECH-Associated Protein 1
This is a "connection" page, showing publications Robert Jotte has written about Kelch-Like ECH-Associated Protein 1.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.181 |
|
|
|
-
West HJ, McCleland M, Cappuzzo F, Reck M, Mok TS, Jotte RM, Nishio M, Kim E, Morris S, Zou W, Shames D, Das Thakur M, Shankar G, Socinski MA. Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial. J Immunother Cancer. 2022 02; 10(2).
Score: 0.181